Journal
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
Volume 17, Issue 1, Pages 53-68Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/17425255.2021.1836157
Keywords
Antibiotics; cystic fibrosis; drug disposition; pharmacodynamics; pharmacokinetics
Ask authors/readers for more resources
Dosage of antibiotics in cystic fibrosis patients is challenging due to altered pharmacokinetics and difficulty in lung tissue penetration. Different antibiotic classes have varying effects on drug metabolism and excretion, with specific guidelines recommended for optimizing therapy. Inhalation therapy can help achieve higher local antibiotic concentrations in the airways, minimizing systemic exposure and toxicity risk.
Introduction Dosing of antibiotics in people with cystic fibrosis (CF) is challenging, due to altered pharmacokinetics, difficulty of lung tissue penetration, and increasing presence of antimicrobial resistance. Areas covered The purpose of this work is to critically review original data as well as previous reviews and guidelines on pharmacokinetics of systemic and inhaled antibiotics in CF, with the aim to propose strategies for optimization of antibacterial therapy in both children and adults with CF. Expert opinion For systemic antibiotics, absorption is comparable in CF patients and non-CF controls. The volume of distribution (Vd) of most antibiotics is similar between people with CF with normal body composition and healthy individuals. However, there are a few exceptions, like cefotiam and tobramycin. Many antibiotic class-dependent changes in drug metabolism and excretion are reported, with an increased total body clearance for ss-lactam antibiotics, aminoglycosides, fluoroquinolones, and trimethoprim. We, therefore, recommend following class-specific guidelines for CF, mostly resulting in higher dosages per kg bodyweight in CF compared to non-CF controls. Higher local antibiotic concentrations in the airways can be obtained by inhalation therapy, with which eradication of bacteria may be achieved while minimizing systemic exposure and risk of toxicity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available